Arrowhead Research Corporation vs Abbvie Inc.
ARWR vs ABBV — side-by-side comparison from reported financials. ARWR leads 5, ABBV leads 5 of 10 comparable metrics.
Arrowhead Research Corporation
ARWR · Healthcare
$62.75+3.31%Solid
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | ARWR | ABBV |
|---|---|---|
| Price | $62.75 | $276.43 |
| Market cap | $8.86B | $488B |
| Revenue (TTM) | $669M | $64.4B |
| Revenue growth | +50.5% | +1.8% |
| Net margin | -47.8% | 9.8% |
| Free cash flow | -$75.1M | $18.2B |
| Net cash (debt) | $478M | ($56.2B) |
| 1-year price return | +74.0% | +19.8% |
| P/E | — | 77.4 |
| P/E vs own history (cheap-side %) | 85% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | -61% | 96% |
| Altman Z-score | 2.52 | 2.33 |
| CV checks passed | 5 of 9 | 9 of 9 |
| Employees | 711 | 57,000 |
Full résumé-style profiles: ARWR CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.